
Oxford Launches Human Trial of New Ebola Vaccine Against Bundibugyo Strain
Oxford begins the first human trial of a Bundibugyo Ebola vaccine, aiming to combat a growing outbreak in Central Africa.
7 articles tagged

Oxford begins the first human trial of a Bundibugyo Ebola vaccine, aiming to combat a growing outbreak in Central Africa.

New research identifies karyoptosis, a process linked to brain cell death in Alzheimer's disease and a potential target for treatments.

PP405 hair loss treatment reactivates dormant stem cells and shows promising hair regrowth results as Phase 3 trials approach.

Pfizer unveils AI-powered cancer research at ASCO 2026, highlighting precision oncology, ADC therapies, and next-generation treatments.

Eli Lilly’s retatrutide delivered up to 30% weight loss in Phase 3 obesity trials, outperforming Wegovy and other GLP-1 therapies.

Learn what hantavirus is, how it spreads, its symptoms, death rate, treatment options, and prevention methods as cases rise worldwide.

A new study shows Vitamin D may boost chemotherapy success by up to 79% in breast cancer patients, offering a simple and affordable treatment support.